Comparing flu vaccines for older adults with HIV
Part of Infections, Lungs & breathing clinical trials.
This study compares two types of flu vaccines (one with an added ingredient to boost the immune response and one without) in people with HIV who are 50 or older. It aims to see which vaccine produces a stronger antibody response, which may help improve flu protection.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 50 years of age or older.
- Your most recent HIV viral load test must be under 330 IU/mL (meaning the virus is under control).
- You must not have had a serious allergic reaction to any flu vaccine in the past.
- You must not have a severe bleeding disorder.
- You must not have already received the flu vaccine for the 2025–2026 season.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two types of flu vaccines for people living with HIV to see which one produces a stronger immune response. It may help you get better protection against the flu.
This study checks how well the seasonal flu vaccine works in people 65 and older who have had flu shots regularly. It compares their immune response to that of younger adults to see if repeated vaccination still protects them.
This trial studies how well your immune system responds to a vaccine in people who are younger adults or, especially, older adults and those with frailty. Your participation may help researchers understand why vaccine responses can differ with age.
This trial tests whether a flu vaccine with an extra ingredient (called an adjuvant) is safer and works better for older Asian adults with chronic health conditions than a standard flu vaccine. It aims to provide better protection against the flu for people like you.
This study compares two types of flu shots for people 65 and older to see which works better. If you are a Kaiser Permanente member and get your flu shot at a Kaiser facility, this trial looks at your health records to see how well the vaccine protected you.
This study tests a new flu vaccine in adults aged 65 and older to see how well it prevents the flu. If you are generally healthy or manage chronic conditions well, you may be able to join.
Hear when a new Antibody Response trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.